Study of Magrolimab (Hu5F9-G4) in Combination With Avelumab in Solid Tumor Participants and Checkpoint-Inhibitor-Naive Ovarian Cancer Participants Who Progress Within 6 Months of Prior Platinum Chemotherapy
Clinical trial NCT03558139 · COMPLETED
Trial details
- NCT number
- NCT03558139
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-23
- Primary completion
- 2020-12-03
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.